首页> 美国卫生研究院文献>Laboratory Animal Research >Toxicity of antioxidative extract collected from Styela clava tunics in ICR mice
【2h】

Toxicity of antioxidative extract collected from Styela clava tunics in ICR mice

机译:从Styela熔岩长袍收集的抗氧化提取物对ICR小鼠的毒性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Some polymers and bioactive compounds derived from Styela clava tunic (SCT) have been reported as traditional medicine for the treatment of inflammation, oxidative stress and surgical wounds although there is little scientific evidence of their liver and kidney toxicity. To investigate the toxicity of ethanol extracts of SCT (EtSCT) in the liver and kidney of ICR mice, alterations in related markers including body weight, organ weight, urine composition, liver pathology and kidney pathology were analyzed following oral administration of 50 and 100 mg/kg body weight/day of EtSCT for 14 days. EtSCT showed a high level of free radical scavenging activity for DPPH (93.1%) and NO (16.2%) as well as the presence of 14.8 mg/mL of flavonoids and 36.2 mg/mL of phenolics, while EtSCT treated groups did not show any significant alterations in the body and organ weight, clinical phenotypes, urine parameters or mice mortality when compared with the vehicle treated group. In addition, constant levels of serum biochemical markers including alanine phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN) and serum creatinine (CRE) were maintained. Moreover, no specific histopathological features induced by most toxic compounds were observed in liver and kidney sections stained with hematoxilin and eosin. Therefore, the present results indicate that EtSCT with strong antioxidant activity cannot induce any specific toxicity in liver and kidney organs of ICR at doses of 100 mg/kg body weight/day.
机译:尽管很少有科学证据证明其衍生自肝脏和肾脏的毒性,但已有报道称衍生自Styela clava束腰外衣(SCT)的某些聚合物和生物活性化合物是用于治疗炎症,氧化应激和手术伤口的传统药物。为了研究SCT(EtSCT)乙醇提取物对ICR小鼠肝脏和肾脏的毒性,在口服50和100 mg后分析了体​​重,器官重量,尿液成分,肝病理和肾脏病理等相关标志物的变化。 / kg体重/ EtSCT天,持续14天。 EtSCT对DPPH(93.1%)和NO(16.2%)表现出高水平的自由基清除活性,并且存在14.8 mg / mL的类黄酮和36.2 mg / mL的酚类,而EtSCT处理组未显示任何与赋形剂治疗组相比,体重和器官重量,临床表型,尿液参数或小鼠死亡率有显着变化。此外,血清生化指标包括丙氨酸磷酸酶(ALP),丙氨酸氨基转移酶(ALT),天冬氨酸氨基转移酶(AST),血尿素氮(BUN)和血清肌酐(CRE)保持恒定水平。此外,在用苏木精和曙红染色的肝和肾切片中未观察到大多数有毒化合物诱导的特定组织病理学特征。因此,本结果表明,具有强抗氧化剂活性的EtSCT在100mg / kg体重/天的剂量下不能在ICR的肝和肾器官中诱导任何特异性毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号